Skip to Main Content

News Center

Center

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

May 7, 2020

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

New Guide Helps Clinicians Optimize Medication Management During COVID-19 Pandemic

April 30, 2020

Guide published by the Peter Lamy Center on Drug Therapy and Aging and US Deprescribing Research Network offers recommendations to improve resident-centered health and reduce opportunities for transmission of COVID-19 in post-acute and long-term care facilities.

SOP Hosts First Mid-Atlantic Metals in Medicine Symposium

December 23, 2019

Event organized by the School’s Metallotherapeutics Research Center brings together regional experts with interest in metal systems to stimulate interaction and collaboration.

Palumbo Named 2019 Founders Week Educator of the Year

October 21, 2019

Well-loved at the School of Pharmacy and the Francis King Carey School of Law, veteran professor is extolled as “an extraordinary teacher and an incredible asset” to UMB.

SOP Collaborates with emocha to Offer Comprehensive Clinical Adherence Solution

October 16, 2019

Leaders in technology and pharmacy collaborate to offer the first technology-enabled adherence solution to fight the country’s deadliest chronic diseases.

M-CERSI Conference Examines Recent Advances in Topical Drug Development

September 10, 2019

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation brings together more than 600 researchers from academia, government, and industry.

M-CERSI Workshop Explores Advances, Challenges in Pediatric Drug Development

September 9, 2019

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.